The Collaborative Science Pilot Awards, a program supported by the Case Western Reserve University—University Hospitals Joint Strategic Leadership Committee, awarded five research teams $50,000 with the possibility of receiving additional funding as scientific milestones are met.
The American Society of Clinical Oncology elected Elizabeth A. Mittendorf to lead as its president beginning in June 2026. Mittendorf, a long-time ASCO member and volunteer, will take office as president-elect immediately following the ASCO Annual Business Meeting in Chicago on June 2.
Last week, The Cancer Letter interviewed City of Hope physician Ravi Salgia, who evacuated from his Eaton Canyon home with his wife on the evening of Jan. 7 due to approaching wildfires driven by the Santa Ana winds.
Northwell Health appointed David J. Chung, a prominent oncologist-investigator, as director of clinical research at the Northwell Health Cancer Institute. In this newly created role, Chung also will serve as system chief of multiple myeloma across Northwell’s cancer centers.
Jennifer A. Woyach, a blood cancer doctor and researcher who has been with Ohio State for more than 12 years, was named director of the Division of Hematology at The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
Roland Dunbrack was named co-leader of the Cancer Signaling and Microenvironment Research Program at Fox Chase Cancer Center alongside the program’s current leader, Edna Cukierman.
The Translational Genomics Research Institute, part of City of Hope, has announced the appointment of John D. Fryer as a professor in the Division of Bioinnovation and Genome Sciences and director of the newly established Center for Accelerated Nanotherapeutics.
An anonymous donor made a $50 million gift to Duke University Health System toward the development of a proton beam therapy center. The donation is the largest philanthropic gift received by Duke University Health System.
Washington University researchers at Siteman Cancer Center received a $10.8 million grant throughNCI’s Specialized Programs of Research Excellence. Led by principal investigator Daniel C. Link, the five-year grant is a renewal of a previous SPORE grant in leukemia.
CureSearch for Children’s Cancer awarded a $225,000 research grant to John Prensner, a physician-scientist at the University of Michigan, to advance research on atypical teratoid/rhabdoid tumors. One of the most aggressive and fatal brain cancers affecting infants and toddlers, ATRT has limited treatment options and devastating outcomes, with more than half of cases proving fatal.
